BeOne Medicines Ltd. Long-term Purchase Commitment, Amount
Financial Statements › Balance Sheet › Liabilities › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2025-11-06
- BeOne Medicines Ltd. long-term purchase commitment, amount for the quarter ending 2025-09-30 was $45.03M, a 26.89% increase year-over-year.
- BeOne Medicines Ltd. long-term purchase commitment, amount for the quarter ending 2025-06-30 was -$22.82M, a 184.97% decline year-over-year.
- BeOne Medicines Ltd. long-term purchase commitment, amount for the quarter ending 2025-03-31 was $152.91M, a 63.52% increase year-over-year.
- BeOne Medicines Ltd. long-term purchase commitment, amount for the quarter ending 2024-09-30 was $35.49M, a 28.68% increase year-over-year.
- BeOne Medicines Ltd. long-term purchase commitment, amount for fiscal 2023 was $169.21M, a 44.26% increase from fiscal 2022.
- BeOne Medicines Ltd. long-term purchase commitment, amount for fiscal 2022 was $117.29M, a 30.47% decline from fiscal 2021.
- BeOne Medicines Ltd. long-term purchase commitment, amount for fiscal 2021 was $168.69M.
| Period end | Long-term Purchase Commitment, Amount 3 month | Long-term Purchase Commitment, Amount 6 month | Long-term Purchase Commitment, Amount 9 month | Long-term Purchase Commitment, Amount 12 month |
|---|---|---|---|---|
| 2025-09-30 | $45.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $22.21M derived: sum of 2 quarters · filed 2025-11-06 | $175.12M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$22.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $130.09M 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | $152.91M 10-Q · filed 2025-05-07 | |||
| 2024-09-30 | $35.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $62.34M derived: sum of 2 quarters · filed 2024-11-12 | $155.85M 10-Q · filed 2024-11-12 | $193.37M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $26.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $120.37M 10-Q · filed 2024-08-07 | $157.88M derived: sum of 3 quarters · filed 2024-08-07 | $185.46M derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | $93.51M 10-Q · filed 2024-05-08 | $131.03M derived: sum of 2 quarters · filed 2024-05-08 | $158.61M derived: sum of 3 quarters · filed 2024-05-08 | $186.63M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | $37.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $65.10M derived: sum of 2 quarters · filed 2024-02-26 | $93.11M derived: sum of 3 quarters · filed 2024-02-26 | $169.21M 10-K · filed 2024-02-26 |
| 2023-09-30 | $27.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $55.60M derived: sum of 2 quarters · filed 2023-11-09 | $131.69M 10-Q · filed 2023-11-09 | $106.79M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $28.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $104.11M 10-Q · filed 2023-08-02 | $79.21M derived: sum of 3 quarters · filed 2023-08-02 | $111.71M derived: sum of 4 quarters · filed 2023-08-02 |
| 2023-03-31 | $76.10M 10-Q · filed 2023-05-04 | $51.19M derived: sum of 2 quarters · filed 2023-05-04 | $83.69M derived: sum of 3 quarters · filed 2023-05-04 | $70.91M derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | -$24.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $7.59M derived: sum of 2 quarters · filed 2023-02-27 | -$5.19M derived: sum of 3 quarters · filed 2023-02-27 | $117.29M 10-K · filed 2023-02-27 |
| 2022-09-30 | $32.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $19.71M derived: sum of 2 quarters · filed 2022-11-09 | $142.20M 10-Q · filed 2022-11-09 | $42.38M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | -$12.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $109.70M 10-Q · filed 2022-08-08 | $9.89M derived: sum of 3 quarters · filed 2022-08-08 | $58.24M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | $122.48M 10-Q · filed 2022-05-09 | $22.67M derived: sum of 2 quarters · filed 2022-05-09 | $71.03M derived: sum of 3 quarters · filed 2022-05-09 | $150.01M derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | -$99.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$51.46M derived: sum of 2 quarters · filed 2022-02-28 | $27.53M derived: sum of 3 quarters · filed 2022-02-28 | $168.69M 10-K · filed 2022-02-28 |
| 2021-09-30 | $48.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $127.34M derived: sum of 2 quarters · filed 2021-11-04 | $268.50M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $78.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $220.15M 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | $141.16M 10-Q · filed 2021-05-06 |